HRT Financial’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.29M Buy
+33,102
New +$4.32M 0.01% 1258
2025
Q4
Sell
-4,922
Closed -$552K 4036
2025
Q3
$552K Buy
+4,922
New +$576K ﹤0.01% 1834
2025
Q2
Sell
-11,469
Closed -$771K 3517
2025
Q1
$771K Buy
+11,469
New +$789K ﹤0.01% 1250
2024
Q2
Sell
-8,559
Closed -$632K 3105
2024
Q1
$632K Buy
+8,559
New +$705K ﹤0.01% 1137
2023
Q4
Sell
-5,438
Closed -$297K 3081
2023
Q3
$297K Sell
5,438
-4,080
-43% -$294K ﹤0.01% 1662
2023
Q2
$799K Sell
9,518
-13,659
-59% -$1.05M 0.01% 1084
2023
Q1
$1.75M Buy
23,177
+17,060
+279% +$1.18M 0.02% 662
2022
Q4
$377K Buy
+6,117
New +$325K 0.01% 1604
2021
Q3
Sell
-8,741
Closed -$290K 3756
2021
Q2
$290K Buy
+8,741
New +$242K ﹤0.01% 2159

Other funds holding TMDX

HRT Financial's TMDX Position: Q1 2026 in Review

HRT Financial opened a new position in Transmedics (TMDX) in Q1 2026: 33,102 shares worth $3.29M. The stake represents 0.01% of the portfolio and ranks #1258 among its holdings. This is a return to the name: HRT Financial previously reported a position in TMDX as recently as Q3 2025.

HRT Financial first reported a position in TMDX in Q2 2021 and has held it in 9 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • HRT Financial held 33,102 shares of Transmedics worth $3.29M as of Q1 2026.
  • Transmedics was a new HRT Financial position in Q1 2026.
  • Transmedics made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1258 holding.
  • HRT Financial first reported a position in Transmedics in Q2 2021 and has held it in 9 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.